THINK Surgical Announces Collaboration with Definition Health

THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced a collaboration with UK based digital health company, Definition Health. The companies will jointly develop a seamless, web-based, connected care solution to enhance the surgical planning experience for surgeons using THINK’s robotic technologies for joint replacement surgery.

This web-based solution will support all of THINK’s robotic products, including new product launches planned for 2023. In addition, this web-based solution will incorporate Definition Health’s Total Digital Surgery platform which assists hospitals and surgeons in achieving workflow efficiency, improved perioperative care and virtual follow up for surgical patients.

Definition Health’s platform is widely deployed in the UK with customers reporting improved profitability for surgical service lines as well as improved patient and provider satisfaction rates. To date, over 100,000 surgical episodes have been managed by customers using this platform.

“We are excited about this collaboration because it will enable a consistent customer experience across of all our products and provide added value options for our customers.” said Stuart Simpson, chief executive officer. “We believe this platform will significantly improve surgeon and patient experience with our robotic technology.”

“We are delighted to launch our digital platform in the USA after our national recognition and success in the UK.” said Sandeep Chauhan, co-founder and chief executive officer of Definition Health. “We look forward to working with THINK and the US surgeon community to help improve care and value-based outcomes for all surgical patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy